To identify the main differences between the treatment of the 'protected' and 'unprotected' groups, let's analyze the reported process variants and their execution times. Here are some observations based on the data provided:

### High Frequency Protected Group Variants
1. **Register at FD -> Examination -> Diagnosis -> Treatment -> Treatment successful -> Discharge (frequency = 269)**
2. **Register at ER -> Examination -> Diagnosis -> Treatment -> Treatment successful -> Discharge (frequency = 284)**
3. **Register at FD -> Expert Examination -> Diagnosis -> Treatment -> Treatment successful -> Discharge (frequency = 179)**

### High Frequency Unprotected Group Variants
1. **Register at FD -> Expert Examination -> Thorough Examination -> Diagnosis -> Treatment -> Treatment successful -> Discharge (frequency = 1466)**
2. **Register at ER -> Expert Examination -> Thorough Examination -> Diagnosis -> Treatment -> Treatment successful -> Discharge (frequency = 1418)**
3. **Register at FD -> Examination -> Thorough Examination -> Diagnosis -> Treatment -> Treatment successful -> Discharge (frequency = 604)**

### Key Differences in Treatment Process

1. **Frequency of Comprehensive Examinations:**
   - The unprotected group frequently undergoes 'Expert Examination' followed by 'Thorough Examination' before reaching a diagnosis and treatment. 
   - The protected group has a higher frequency of bypassing these steps and directly going to 'Examination' or 'Expert Examination' only.

2. **Treatment Success Rate:**
   - Both groups have successful discharges in most process variants. However, instances of 'Treatment unsuccessful' leading to multiple rounds of diagnosis and treatment are more frequent in the protected group.

3. **Performance Times:**
   - The higher-frequency variants in the protected group have similar average performance times to those in the unprotected group. However, the unprotected group's high-frequency variants generally involve more thorough examinations and thus longer average performance times.
   - Variants involving 'Thorough Examination' in the unprotected group have notably longer performance times, suggesting more time is spent ensuring a comprehensive assessment.

4. **Discharge Observed:**
   - The protected group has significantly fewer instances of only "Discharge" without any preceding steps, indicating more registration and treatment activities compared to the unprotected group. This could either suggest differences in initial screenings or triage processes.

### Unprotected Group's Process Efficiency and Accuracy:
- The inclusion of 'Thorough Examination' and 'Expert Examination' in the high-frequency variants for the unprotected group may indicate a more rigorous and personalized approach to treatment, which could justify the longer performance times.
- Successful discharge rates seem to be maintained, if not improved, suggesting that the thorough examination does not negatively impact treatment outcome efficacy.

### Protected Group's Process Efficiency and Accuracy:
- Despite the presence of 'Treatment unsuccessful' in many variants, the overall process times for individual variants are similar to those in the unprotected group.
- The lack of thorough and expert examinations in high-frequency variants for the protected group might suggest a different triage strategy or possibly more straightforward patient conditions that do not warrant complex evaluations.

### Implications and Unfair Differences:
- The major implication here is that the unprotected group is more frequently subject to comprehensive and highly specialized evaluations, which might be both time-consuming and resource-intensive.
- The higher frequency of complex treatment processes for the unprotected group could indicate a potential unfairness if resources were being redirected disproportionately away from the protected group, leading to less rigorous treatment for the latter group.

### Potential Recommendations:
1. **Resource Allocation Review:** Ensure that resources are adequately distributed to avoid discrepancies in treatment rigour between the groups.
2. **Quality Assurance Protocol Check:** Ensure that both groups receive consistent levels of care and that any differences in treatment are evidence-based and not discriminatory.
3. **Data-Driven Decision Making:** Use more advanced analytics to monitor and adjust processes dynamically, ensuring equitable treatment across groups.
4. **Quality Control and Accountability:** Implement and enforce strict quality control measures to verify consistency in treatment protocols and outcomes for both groups. 

Understanding and addressing these differences is crucial to ensuring fair and equitable healthcare delivery.